Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Amid Stronger Than Expected Retail Performance, CVS Health Boosts 2021 Guidance

CVS Health Corp (NYSE:CVS) boosted its 2021 guidance ahead of its fourth-quarter earnings in early February, with executives citing better-than-expected performance in its retail segment.

  • In an SEC filing, the Company raised its full-year earnings projections to $8.33 - $8.38 per share from a previous estimate of $8
  • The Company also affirmed its 2022 guidance of $8.10 - $8.30 per share.
  • RelatedCVS Plans 900 Store Closures Over Three Years.
  • During the annual J.P. Morgan Healthcare Conference, CVS's chief financial officer, Shawn Guertin, said the retail business's strong results in the fourth quarter account for about 80% of the overperformance CVS saw.
  • See the Company presentation here.
  • As COVID-19 pandemic response, the Company administered around 59 million vaccines and about 32 million tests.
  • Price Action: CVS shares are up 0.85% at $105.95 during the market session on the last check Tuesday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.